Weiyang Lou

2.5k total citations
42 papers, 1.8k citations indexed

About

Weiyang Lou is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Weiyang Lou has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 29 papers in Cancer Research and 5 papers in Organic Chemistry. Recurrent topics in Weiyang Lou's work include Cancer-related molecular mechanisms research (21 papers), MicroRNA in disease regulation (19 papers) and Circular RNAs in diseases (17 papers). Weiyang Lou is often cited by papers focused on Cancer-related molecular mechanisms research (21 papers), MicroRNA in disease regulation (19 papers) and Circular RNAs in diseases (17 papers). Weiyang Lou collaborates with scholars based in China, Singapore and United States. Weiyang Lou's co-authors include Bisha Ding, Weimin Fan, Guansheng Zhong, Peifen Fu, Liang Xu, Chang Bao, Weimin Fan, Yi Yan Yang, Junjie Zhang and Jin‐Xing Liu and has published in prestigious journals such as Nature Communications, Biomaterials and Acta Biomaterialia.

In The Last Decade

Weiyang Lou

40 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiyang Lou China 24 1.2k 931 302 261 192 42 1.8k
Guansheng Zhong China 18 686 0.6× 412 0.4× 338 1.1× 288 1.1× 106 0.6× 39 1.3k
Chang Bao China 13 587 0.5× 346 0.4× 268 0.9× 220 0.8× 76 0.4× 17 993
Xueyan Zhang China 24 761 0.6× 162 0.2× 77 0.3× 81 0.3× 80 0.4× 51 1.4k
Barbara Dapas Italy 25 936 0.8× 300 0.3× 70 0.2× 29 0.1× 103 0.5× 70 1.6k
Alan Soo Beng Khoo Malaysia 22 1.3k 1.0× 420 0.5× 84 0.3× 25 0.1× 292 1.5× 66 2.2k
Subhayan Das India 20 565 0.5× 231 0.2× 60 0.2× 44 0.2× 61 0.3× 56 1.1k
Xiong-Bin Hu China 19 1.1k 0.9× 492 0.5× 37 0.1× 40 0.2× 62 0.3× 34 1.5k

Countries citing papers authored by Weiyang Lou

Since Specialization
Citations

This map shows the geographic impact of Weiyang Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyang Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyang Lou more than expected).

Fields of papers citing papers by Weiyang Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyang Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyang Lou. The network helps show where Weiyang Lou may publish in the future.

Co-authorship network of co-authors of Weiyang Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyang Lou. A scholar is included among the top collaborators of Weiyang Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyang Lou. Weiyang Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Guansheng, et al.. (2024). CPSF4-mediated regulation of alternative splicing of HMG20B facilitates the progression of triple-negative breast cancer. Journal of Translational Medicine. 22(1). 1149–1149.
2.
3.
4.
5.
Zhou, Wei, Weiyang Lou, Junru Chen, et al.. (2021). AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest. OncoTargets and Therapy. Volume 14. 1049–1059. 3 indexed citations
6.
Lou, Weiyang, Wenlong Wang, Jing Chen, Shuqian Wang, & Yu‐An Huang. (2021). ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma. Molecular Therapy — Nucleic Acids. 24. 845–855. 42 indexed citations
7.
Zheng, Huilin, et al.. (2021). Construction of a lncRNA/pseudogene-hsa-miR-30d-5p-GJA1 regulatory network related to metastasis of pancreatic cancer. Genomics. 113(4). 1742–1753. 15 indexed citations
8.
Lou, Weiyang, Jing Chen, Bisha Ding, & Weimin Fan. (2021). XIAP, commonly targeted by tumor suppressive miR-3607-5p and miR-3607-3p, promotes proliferation and inhibits apoptosis in hepatocellular carcinoma. Genomics. 113(3). 933–945. 11 indexed citations
9.
Yang, Hao, Shan Gao, Jing Chen, & Weiyang Lou. (2020). UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma. Cancer Cell International. 20(1). 234–234. 21 indexed citations
10.
Lou, Weiyang, et al.. (2020). Integrated Analysis of Distant Metastasis-Associated Genes and Potential Drugs in Colon Adenocarcinoma. Frontiers in Oncology. 10. 576615–576615. 11 indexed citations
11.
Lou, Weiyang, Bisha Ding, & Peifen Fu. (2020). Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer. Frontiers in Cell and Developmental Biology. 8. 85–85. 114 indexed citations
12.
Lou, Weiyang, Bisha Ding, Guansheng Zhong, et al.. (2020). RP11-480I12.5-004 Promotes Growth and Tumorigenesis of Breast Cancer by Relieving miR-29c-3p-Mediated AKT3 and CDK6 Degradation. Molecular Therapy — Nucleic Acids. 21. 916–931. 23 indexed citations
13.
Bao, Chang, Danni Chen, Yunkun Lu, et al.. (2020). MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1. Cell Death and Disease. 11(8). 618–618. 44 indexed citations
14.
Chen, Xu, Weiyang Lou, Jin‐Xing Liu, et al.. (2019). A novel antimicrobial polymer efficiently treats multidrug-resistant MRSA-induced bloodstream infection. Bioscience Reports. 39(10). 14 indexed citations
15.
Yang, Chuan, Weiyang Lou, Guansheng Zhong, et al.. (2019). Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice. Acta Biomaterialia. 94. 268–280. 45 indexed citations
16.
Chen, Jing, Weiyang Lou, Bisha Ding, & Xian Wang. (2019). Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers. Aging. 11(15). 5666–5688. 35 indexed citations
17.
Lou, Weiyang, Jin‐Xing Liu, Bisha Ding, et al.. (2019). Identification of potential miRNA–mRNA regulatory network contributing to pathogenesis of HBV-related HCC. Journal of Translational Medicine. 17(1). 7–7. 77 indexed citations
18.
Chin, Willy, Guansheng Zhong, Qinqin Pu, et al.. (2018). A macromolecular approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset. Nature Communications. 9(1). 917–917. 282 indexed citations
19.
Ding, Bisha, Weiyang Lou, Liang Xu, & Weimin Fan. (2018). Non-coding RNA in drug resistance of hepatocellular carcinoma. Bioscience Reports. 38(5). 81 indexed citations
20.
Chen, Danni, Jiaying Shen, Chengyong Du, et al.. (2018). miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells. Cell Death and Disease. 9(2). 188–188. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guansheng Zhong Breakdown of academic impact, for papers by Chang Bao Breakdown of academic impact, for papers by Xueyan Zhang Breakdown of academic impact, for papers by Barbara Dapas Breakdown of academic impact, for papers by Alan Soo Beng Khoo Breakdown of academic impact, for papers by Subhayan Das Breakdown of academic impact, for papers by Xiong-Bin Hu
Rankless by CCL
2026